Elevated CXCL12 in the plasma membrane of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a potential prognostic marker

Background: Neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) has been shown to improve sphincter preservation and local pelvic control, but the efficacy of nCRT plateaus due to metastasis. CXC chemokine ligand 12 (CXCL12) has a critical impact on cancer development and m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sup, Yeo, Min-Kyung, Kim, Jun-Sang, Kim, Ji-Yeon, Kim, Kyung-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692683/
https://www.ncbi.nlm.nih.gov/pubmed/34976180
http://dx.doi.org/10.7150/jca.64082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692683/
https://www.ncbi.nlm.nih.gov/pubmed/34976180
http://dx.doi.org/10.7150/jca.64082

Ejemplares similares